Author:
Guerrini Marco,Beccati Daniela,Shriver Zachary,Naggi Annamaria,Viswanathan Karthik,Bisio Antonella,Capila Ishan,Lansing Jonathan C,Guglieri Sara,Fraser Blair,Al-Hakim Ali,Gunay Nur Sibel,Zhang Zhenqing,Robinson Luke,Buhse Lucinda,Nasr Moheb,Woodcock Janet,Langer Robert,Venkataraman Ganesh,Linhardt Robert J,Casu Benito,Torri Giangiacomo,Sasisekharan Ram
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference30 articles.
1. Capila, I. & Linhardt, R.J. Heparin-protein interactions. Angew. Chem. Int. Edn. Engl. 41, 391–412 (2002).
2. Lepor, N.E. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. Rev. Cardiovasc. Med. 8 (suppl. 3), S9–S17 (2007).
3. Fischer, K.G. Essentials of anticoagulation in hemodialysis. Hemodial. Int. 11, 178–189 (2007).
4. Contaminant detected in heparin material of specified origin in the USA and in Germany; serious adverse events reported; recall measures initiated. World Health Organization Alert No. 118 (7 March 2008). < http://www.who.int/medicines/publications/ drugalerts/Alert_118_Heparin.pdf >
5. 2. Notice of Recall from Rotexmedica to Bfarm (German Regulatory Authorities). Rotexmedica/Bfarm Notice (7 March 2008). <
Cited by
541 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献